Rain lashed against the panoramic windows of Cassandra "Cassie" Thorne's 42nd-floor office, blurring the already fading twilight of a Manhattan November evening.  The city lights, normally a vibrant tapestry spread below, were diffused into shimmering halos by the downpour. Cassie, Chief Operating Officer of Thorne & Sterling Pharmaceuticals, tapped a manicured nail against the cool glass, her brow furrowed in concentration.  Her reflection, a sharp image of professional elegance in a tailored navy suit, stared back at her with an unnerving calm that belied the storm brewing both inside and outside. The mahogany desk behind her, usually a model of organized efficiency, was strewn with spreadsheets, market analysis reports, and a half-eaten container of lukewarm takeout sushi.  Something was off.  The numbers weren't adding up, and a nagging feeling, a prickle of unease she couldn't quite place, had been unsettling her for days.  It started subtly, a whispered doubt in the back of her mind, but now it resonated with every drop of rain, each flicker of the city lights â€“ a premonition that the meticulously crafted world she had built was about to shatter.
